XML 20 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Cash flows from operating activities:          
Net income $ 36,997 $ (48,022) $ 149,058 $ 54,611  
Adjustments to reconcile net income to net cash provided by operating activities:          
Depreciation and amortization     53,644 35,946  
Bad debt allowance     5,199 466  
Deferred income taxes     (13,670) (17,788)  
Stock-based compensation expense     51,359 32,853  
Deferred compensation plan     (21,873) 89,327  
Amortization and write-off of deferred debt issuance costs     5,468 4,160  
Change in fair value of derivative     (29,318) (9,198)  
Foreign currency remeasurement loss     14,445 103  
Other non-cash items, net     (1,006) 2,939  
Changes in assets and liabilities, net of effect from acquisitions:          
Accounts receivable     12,550 26,305  
Prepaid and other assets     7,779 11,310  
Accounts payable, accruals, and other liabilities     28,765 29,047  
Deferred revenues     (26,725) (40,496)  
Income taxes payable, net of prepaid income taxes     2,523 (12,168)  
Net cash provided by operating activities     238,198 207,417  
Cash flows from investing activities:          
Purchases of property and equipment and investment in capitalized software     (12,982) (11,152)  
Proceeds from sale of aircraft     2,380 0  
Acquisitions, net of cash acquired     (719,539) (1,033,695)  
Other investing activities     (10,304) (3,000)  
Net cash used in investing activities     (740,445) (1,047,847)  
Cash flows from financing activities:          
Proceeds from credit facilities     753,376 682,083  
Payments of credit facilities     (408,714) (860,228)  
Proceeds from convertible senior notes, net of discounts and commissions     0 1,233,377  
Payments of debt issuance costs     0 (5,643)  
Purchase of capped call options     0 (51,555)  
Repayment of term loan     (3,750) 0  
Payments of financing leases     (123) (147)  
Payments of acquisition debt and other consideration     (6,996) (741)  
Payments of dividends     (25,828) (25,076)  
Proceeds from stock purchases under employee stock purchase plan     10,335 3,846  
Proceeds from exercise of stock options     6,855 5,039  
Payments for shares acquired including shares withheld for taxes     (42,213) (111,306)  
Repurchase of Class B Common Stock under approved program     (28,250) 0  
Net cash provided by financing activities     254,692 869,649  
Effect of exchange rate changes on cash and cash equivalents     (8,926) 4,530  
(Decrease) increase in cash and cash equivalents     (256,481) 33,749  
Cash and cash equivalents, beginning of year     329,337 122,006 $ 122,006
Cash and cash equivalents, end of period $ 72,856 $ 155,755 72,856 155,755 $ 329,337
Supplemental information:          
Cash paid for income taxes     20,696 32,359  
Income tax refunds     2,194 7,820  
Interest paid     17,647 3,281  
Non-cash investing and financing activities:          
Cost method investment, non-cash exchange     6,022 0  
Shares issued related to acquisition     0 182,390  
Contingent acquisition consideration     0 5,581  
Deferred, non-contingent consideration, net     157 10,081  
Convertible senior notes expenses included in Accounts payable     0 375  
Capped call options expenses included in Accounts payable     0 50  
Share-settled Executive Bonus Plan awards     16,310 16,015  
Deferred compensation plan elective participant deferrals     $ 4,694 $ 2,020